Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma

This study aimed to identify the prognostic subgroups of stage 4 high-risk neuroblastoma based on metastatic burden and explore their distinct clinical and genomic features. Patients aged ≥18 months with stage 4 and metaiodobenzylguanidine-avid neuroblastoma were enrolled. One hundred and thirty eli...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Eun Seop, Lee, Eun-jin, Lee, Boram, Shin, Muheon, Cho, Young-Seok, Hyun, Ju Kyung, Cho, Hee Won, Ju, Hee Young, Yoo, Keon Hee, Koo, Hong Hoe, Lee, Ji Won, Sung, Ki Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565784/
https://www.ncbi.nlm.nih.gov/pubmed/32847064
http://dx.doi.org/10.3390/jcm9092730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565784/
https://www.ncbi.nlm.nih.gov/pubmed/32847064
http://dx.doi.org/10.3390/jcm9092730

Ejemplares similares